|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-23-310267 |
H00165140-B01P |
5-oxo-ETE GPCR Antibody//Human/Mouse |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
5-oxo-ETE GPCR Antibody |
Description
|
/ Human/Mouse |
Clonality
|
Poly |
Company
|
Novus biologicals |
Application
|
ELISA, Western Blot |
Conjugation
|
|
Immunogen
|
|
Contents
|
Description:Summary: Protein Type: | Full length Protein | Species: | Hu | Applications: | WB, ELISA | Clonality: | Polyclonal | | Gene: | OXER1 | Purity: | protein A purified | Host: | Mouse | | Specificity: | Reacts with oxoeicosanoid (OXE) receptor 1. | Details: Immunogen: | OXER1 (NP_683765.1, 1 a.a. ~ 423 a.a) full-length human protein. | Epitope: | MLCHRGGQLIVPIIPLCPEHSCRGRR LQNLLSGPWPKQPMELHNLSSPSPSL SSSVLPPSFSPSPSSAPSAFTTVGGS SGGPCHPTSSSLVSAFLAPILALEFV LGLVGNSLALFIFCIHTRPWTSNTVF LVSLVAADFLLISNLPLRVDYYLLHE TWRFGAAACKVNLFMLSTNRTASVVF LTAIALNRYLKVVQPHHVLSRASVGA AARVAGGLWVGILLLNGHLLLSTFSG PSCLSYRVGTKPSASLRWHQA | Gene Symbol: OXER1 Entrez: | 165140 (Human) | Swiss Prot: | NP_683765.1 (Human) | Related Genes: | RHO, EGFR, MAPK1, ARRB1, ADRBK1, PIK3CG, MAPK3, AKT1, EPHB2, EGF, LPA, AGT, SRC, GRK, PKC, ADCY7, PTH, MAPK12, POMC, PIK3CB, PIK3CD, PTK2B, HSPG2, MBTPS1, PIK3CA, PSMC6, NR1I2, CCR5, SST, KNG1, CNR1, F2R, NTS, EPHA3, NPY, GRK5, CXCR4, ADRBK2, C5AR1, PKA | Species: Applications: Uses: | This antibody is reactive against tissue and transfected lysate in western blot, and as a detection antibody in ELISA. | Dilutions: | ELISA,Western Blot | Notes: Genbank Accession: NM_148962.3 This product is produced by and distributed for Abnova, a company based in Taiwan. Packaging: Buffer: | 1x PBS, pH 7.2 | Storage: | Store at -20C. Avoid freeze-thaw cycles. | Preservative: | No Preservative | Limitations: | This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months. | |
|
|
|
|